Cachexia: A systemic consequence of progressive, unresolved disease

M Ferrer, TG Anthony, JS Ayres, G Biffi, JC Brown… - Cell, 2023 - cell.com
Cachexia, a systemic wasting condition, is considered a late consequence of diseases,
including cancer, organ failure, or infections, and contributes to significant morbidity and …

Role of the intestinal microbiota in contributing to weight disorders and associated comorbidities

M Van Hul, AM Neyrinck, A Everard… - Clinical microbiology …, 2024 - journals.asm.org
The gut microbiota is a major factor contributing to the regulation of energy homeostasis and
has been linked to both excessive body weight and accumulation of fat mass (ie, overweight …

Inhibiting de novo ceramide synthesis restores mitochondrial and protein homeostasis in muscle aging

TI Lima, PP Laurila, M Wohlwend, JD Morel… - Science Translational …, 2023 - science.org
Disruption of mitochondrial function and protein homeostasis plays a central role in aging.
However, how these processes interact and what governs their failure in aging remain …

The key role of sphingolipid metabolism in cancer: New therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance

RZ Li, XR Wang, J Wang, C Xie, XX Wang… - Frontiers in …, 2022 - frontiersin.org
Biologically active sphingolipids are closely related to the growth, differentiation, aging, and
apoptosis of cancer cells. Some sphingolipids, such as ceramides, are favorable metabolites …

Virtual reality-empowered deep-learning analysis of brain cells

D Kaltenecker, R Al-Maskari, M Negwer, L Hoeher… - Nature …, 2024 - nature.com
Automated detection of specific cells in three-dimensional datasets such as whole-brain light-
sheet image stacks is challenging. Here, we present DELiVR, a virtual reality-trained deep …

Interleukin‐6 initiates muscle‐and adipose tissue wasting in a novel C57BL/6 model of cancer‐associated cachexia

I Pototschnig, U Feiler, C Diwoky… - Journal of cachexia …, 2023 - Wiley Online Library
Background Cancer‐associated cachexia (CAC) is a wasting syndrome drastically reducing
efficacy of chemotherapy and life expectancy of patients. CAC affects up to 80% of cancer …

Development of a peptide drug restoring AMPK and adipose tissue functionality in cancer cachexia

H Ji, F Englmaier, P Morigny, M Giroud, P Gräsle… - Molecular Therapy, 2023 - cell.com
Cancer cachexia is a severe systemic wasting disease that negatively affects quality of life
and survival in patients with cancer. To date, treating cancer cachexia is still a major unmet …

Trip13 depletion in liver cancer induces a lipogenic response contributing to Plin2‐dependent mitotic cell death

M Rios Garcia, B Meissburger, J Chan… - Advanced …, 2022 - Wiley Online Library
Aberrant energy metabolism and cell cycle regulation both critically contribute to malignant
cell growth and both processes represent targets for anticancer therapy. It is shown here that …

Cancer cachexia: multilevel metabolic dysfunction

M Berriel Diaz, M Rohm, S Herzig - Nature Metabolism, 2024 - nature.com
Cancer cachexia is a complex metabolic disorder marked by unintentional body weight loss
or 'wasting'of body mass, driven by multiple aetiological factors operating at various levels. It …

The burning furnace: Alteration in lipid metabolism in cancer-associated cachexia

M Joshi, BM Patel - Molecular and Cellular Biochemistry, 2022 - Springer
Cancer cachexia can be defined as a complex metabolic syndrome characterized by weight
loss, anorexia, and emaciation due to the wasting of adipose tissue and skeletal muscle. In …